Wei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Wang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Fangqi Gong
Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
2 shared publications Haiyan Xu
ECG room, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescent’s Health and Diseases, Hangzhou, China
2 shared publications- Yujia Wang
Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, People’s Republic of China
2 shared publications Fangqi Gong
Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, China
1 shared publication- Fanqing Xu
Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents’ Health and Diseases, Hangzhou 310052, China
1 shared publication - Haiyan Xu
Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents’ Health and Diseases, Hangzhou 310052, China
1 shared publication
Latest Publications
- Open Access
Dynamic Pre-Excitation and Sequential Ablation of Three Distinct Right-Sided Accessory Pathway Sites in a Child with Wolff–Parkinson–White Syndrome: A Case Report
Background: Multiple accessory pathways are uncommon in pediatric Wolff–Parkinson–White syndrome and may cause dynamic changes in ventricular pre-excitation, complicating electrocardiographic localization. Case presentation: A 7-year-old girl with recurrent palpitations and syncope exhibited variable QRS morphology and delta-wave patterns. Electrophysiological findings were consistent with orthodromic atrioventricular reentrant tachycardia. Sequential CARTO mapping identified three spatially separated right-sided accessory pathway sites. Ablation of AP1 (7 o’clock, tricuspid annulus) and AP2 (11 o’clock, tricuspid annulus) produced successive QRS morphological changes without eliminating pre-excitation. AP3 was localized just superior to the coronary sinus ostium at approximately the 4 o’clock position, where ablation eliminated pre-excitation. No tachycardia was inducible immediately afterward. However, pre-excitation reappeared on ECG at 1-month follow-up and persisted at 3 months, with two patient-reported tachycardia episodes but no recurrent syncope. Conclusions: Dynamic pre-excitation patterns may suggest multiple accessory pathways. Sequential mapping and electrocardiographic reassessment can help identify residual pathway conduction, although acute procedural success does not ensure sustained elimination of pre-excitation.
Open AccessDynamic Pre-Excitation and Sequential Ablation of Three Distinct Right-Sided Accessory Pathway Sites in a Child with Wolff–Parkinson–White Syndrome: A Case Report
Background: Multiple accessory pathways are uncommon in pediatric Wolff–Parkinson–White syndrome and may cause dynamic changes in ventricular pre-excitation, complicating electrocardiographic localization. Case presentation: A 7-year-old girl with recurrent palpitations and syncope exhibited variable QRS morphology and delta-wave patterns. Electrophysiological findings were consistent with orthodromic atrioventricular reentrant tachycardia. Sequential CARTO mapping identified three spatially separated right-sided accessory pathway sites. Ablation of AP1 (7 o’clock, tricuspid annulus) and AP2 (11 o’clock, tricuspid annulus) produced successive QRS morphological changes without eliminating pre-excitation. AP3 was localized just superior to the coronary sinus ostium at approximately the 4 o’clock position, where ablation eliminated pre-excitation. No tachycardia was inducible immediately afterward. However, pre-excitation reappeared on ECG at 1-month follow-up and persisted at 3 months, with two patient-reported tachycardia episodes but no recurrent syncope. Conclusions: Dynamic pre-excitation patterns may suggest multiple accessory pathways. Sequential mapping and electrocardiographic reassessment can help identify residual pathway conduction, although acute procedural success does not ensure sustained elimination of pre-excitation.
- Open Access
- 15 September 2026
- Published by Springer Nature in Scientific Data
A Large-Scale Standardized Pediatric Normal Electrocardiogram Dataset
- 15 September 2026
- Published by Springer Nature in Scientific Data
Open AccessA Large-Scale Standardized Pediatric Normal Electrocardiogram Dataset
- Open Access
- 15 July 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (7) , 332
Extravascular Implantable Cardioverter-Defibrillator Therapy for Malignant Ventricular Arrhythmias in a Child with Congenital Long QT Syndrome: A Case Report
Background/Objectives: Children with congenital long QT syndrome (cLQTS) are at extremely high risk of torsades de pointes (TdP) and sudden cardiac death (SCD). Although the implantable cardioverter-defibrillator (ICD) is a cornerstone in SCD prevention, traditional transvenous ICDs are associated with venous access occupation, lead wear or fracture due to somatic growth, and difficulties with long-term lead revision or extraction. The extravascular ICD, which places the lead in the substernal extravascular space, has the potential to circumvent these lead-related complications. We report the experience of successful extravascular ICD implantation in a young child with drug-refractory cLQTS type 2 (cLQTS2). Methods: The clinical data of a 9-year-old boy with cLQTS2 were retrospectively analyzed. The patient carried a heterozygous KCNH2 variant (c.1810G>A, p.Gly604Ser) and had been on long-term oral propranolol and mexiletine. He presented with a cardiac arrest out of hospital during nocturnal sleep, was transferred to our hospital after successful cardiopulmonary resuscitation, and had TdP captured on ambulatory monitoring. Following multidisciplinary discussion, preoperative chest computed tomography (CT) assessment of the substernal anatomy, and informed consent, extravascular ICD implantation was performed on hospital day 11. The procedure involved the creation of a substernal tunnel via a subxiphoid incision, placement of the defibrillation lead in the anterior mediastinum with lead slack reserved for growth, and positioning of the pulse generator in a left axillary subcutaneous pocket. Intraoperative defibrillation testing succeeded with a single 30 J shock. Results: The postoperative recovery was uneventful without procedure-related complications. At the 2-month follow-up, device parameters were satisfactory and no inappropriate shocks had occurred. The corrected QT interval (QTc) decreased from 563 ms on admission to 522 ms. Ambulatory monitoring detected asymptomatic episodes of non-sustained ventricular tachycardia, but no ventricular fibrillation or syncope was observed. Venous access was fully preserved. Conclusions: In children with drug-refractory cLQTS2, the extravascular ICD provides defibrillation and antitachycardia pacing (ATP) while avoiding transvenous lead complications and preserving venous access. This case shows that with precise preoperative planning and lead redundancy, the device appears feasible and can be implanted without short-term complications in young children. Larger studies with longer follow-up are needed to evaluate long-term device performance.
- 15 July 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (7) , 332
Open AccessExtravascular Implantable Cardioverter-Defibrillator Therapy for Malignant Ventricular Arrhythmias in a Child with Congenital Long QT Syndrome: A Case Report
Background/Objectives: Children with congenital long QT syndrome (cLQTS) are at extremely high risk of torsades de pointes (TdP) and sudden cardiac death (SCD). Although the implantable cardioverter-defibrillator (ICD) is a cornerstone in SCD prevention, traditional transvenous ICDs are associated with venous access occupation, lead wear or fracture due to somatic growth, and difficulties with long-term lead revision or extraction. The extravascular ICD, which places the lead in the substernal extravascular space, has the potential to circumvent these lead-related complications. We report the experience of successful extravascular ICD implantation in a young child with drug-refractory cLQTS type 2 (cLQTS2). Methods: The clinical data of a 9-year-old boy with cLQTS2 were retrospectively analyzed. The patient carried a heterozygous KCNH2 variant (c.1810G>A, p.Gly604Ser) and had been on long-term oral propranolol and mexiletine. He presented with a cardiac arrest out of hospital during nocturnal sleep, was transferred to our hospital after successful cardiopulmonary resuscitation, and had TdP captured on ambulatory monitoring. Following multidisciplinary discussion, preoperative chest computed tomography (CT) assessment of the substernal anatomy, and informed consent, extravascular ICD implantation was performed on hospital day 11. The procedure involved the creation of a substernal tunnel via a subxiphoid incision, placement of the defibrillation lead in the anterior mediastinum with lead slack reserved for growth, and positioning of the pulse generator in a left axillary subcutaneous pocket. Intraoperative defibrillation testing succeeded with a single 30 J shock. Results: The postoperative recovery was uneventful without procedure-related complications. At the 2-month follow-up, device parameters were satisfactory and no inappropriate shocks had occurred. The corrected QT interval (QTc) decreased from 563 ms on admission to 522 ms. Ambulatory monitoring detected asymptomatic episodes of non-sustained ventricular tachycardia, but no ventricular fibrillation or syncope was observed. Venous access was fully preserved. Conclusions: In children with drug-refractory cLQTS2, the extravascular ICD provides defibrillation and antitachycardia pacing (ATP) while avoiding transvenous lead complications and preserving venous access. This case shows that with precise preoperative planning and lead redundancy, the device appears feasible and can be implanted without short-term complications in young children. Larger studies with longer follow-up are needed to evaluate long-term device performance.
- Open Access
- 3 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (19) , 107762
Integrated Management of Malignant Arrhythmias in Pediatric LMNA-Related Cardiomyopathy Using Active-Fixation CRT-D
- 3 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (19) , 107762
Open AccessIntegrated Management of Malignant Arrhythmias in Pediatric LMNA-Related Cardiomyopathy Using Active-Fixation CRT-D
- Open Access
- 28 March 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (4) , 500
The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease
The EphrinB2/EphB4 signaling pathway involves the regulation of vascular morphogenesis and angiogenesis. However, little is known about EphrinB2/EphB4 in the pathogenesis of Kawasaki disease (KD) and coronary artery aneurysm formation. Hence, this study aimed to explore the role of EphrinB2/EphB4 and the potential therapeutic effect of EphrinB2-Fc in the coronary arterial endothelial injury of KD. The levels of EphB4 were compared between KD patients and healthy children. Human coronary artery endothelial cells (HCAECs) were stimulated with sera from acute KD patients to establish the KD cell model. The overexpression of EphB4 or treatment with EphrinB2-Fc was found to intervene in the cell model. The cell migration, angiogenesis, and proliferation ability were assessed, and the expression of inflammation-related factors was measured. Our study showed that EphB4 showed low expression in both KD patients and the cell model of KD. The EphB4 protein levels in the CECs of CAA+ KD patients were much lower than those in healthy children. EphrinB2-Fc treatment of KD sera-activated HCAECs suppressed cell proliferation, reduced the expression of inflammation-related factors (such as IL-6 and P-selectin), and elevated cell angiogenesis ability. The results reveal that EphrinB2-Fc has a protective function in endothelial cells and has promising clinical applications for protecting vascular endothelium in patients with KD.
- 28 March 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (4) , 500
Open AccessThe Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease
The EphrinB2/EphB4 signaling pathway involves the regulation of vascular morphogenesis and angiogenesis. However, little is known about EphrinB2/EphB4 in the pathogenesis of Kawasaki disease (KD) and coronary artery aneurysm formation. Hence, this study aimed to explore the role of EphrinB2/EphB4 and the potential therapeutic effect of EphrinB2-Fc in the coronary arterial endothelial injury of KD. The levels of EphB4 were compared between KD patients and healthy children. Human coronary artery endothelial cells (HCAECs) were stimulated with sera from acute KD patients to establish the KD cell model. The overexpression of EphB4 or treatment with EphrinB2-Fc was found to intervene in the cell model. The cell migration, angiogenesis, and proliferation ability were assessed, and the expression of inflammation-related factors was measured. Our study showed that EphB4 showed low expression in both KD patients and the cell model of KD. The EphB4 protein levels in the CECs of CAA+ KD patients were much lower than those in healthy children. EphrinB2-Fc treatment of KD sera-activated HCAECs suppressed cell proliferation, reduced the expression of inflammation-related factors (such as IL-6 and P-selectin), and elevated cell angiogenesis ability. The results reveal that EphrinB2-Fc has a protective function in endothelial cells and has promising clinical applications for protecting vascular endothelium in patients with KD.